Literature DB >> 26059245

Production of human lactoferrin and lysozyme in the milk of transgenic dairy animals: past, present, and future.

Caitlin A Cooper1, Elizabeth A Maga, James D Murray.   

Abstract

Genetic engineering, which was first developed in the 1980s, allows for specific additions to animals' genomes that are not possible through conventional breeding. Using genetic engineering to improve agricultural animals was first suggested when the technology was in the early stages of development by Palmiter et al. (Nature 300:611-615, 1982). One of the first agricultural applications identified was generating transgenic dairy animals that could produce altered or novel proteins in their milk. Human milk contains high levels of antimicrobial proteins that are found in low concentrations in the milk of ruminants, including the antimicrobial proteins lactoferrin and lysozyme. Lactoferrin and lysozyme are both part of the innate immune system and are secreted in tears, mucus, and throughout the gastrointestinal (GI) tract. Due to their antimicrobial properties and abundance in human milk, multiple lines of transgenic dairy animals that produce either human lactoferrin or human lysozyme have been developed. The focus of this review is to catalogue the different lines of genetically engineered dairy animals that produce either recombinant lactoferrin or lysozyme that have been generated over the years as well as compare the wealth of research that has been done on the in vitro and in vivo effects of the milk they produce. While recent advances including the development of CRISPRs and TALENs have removed many of the technical barriers to predictable and efficient genetic engineering in agricultural species, there are still many political and regulatory hurdles before genetic engineering can be used in agriculture. It is important to consider the substantial amount of work that has been done thus far on well established lines of genetically engineered animals evaluating both the animals themselves and the products they yield to identify the most effective path forward for future research and acceptance of this technology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26059245     DOI: 10.1007/s11248-015-9885-5

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  87 in total

1.  Growth enhancement in transgenic Atlantic salmon by the use of an "all fish" chimeric growth hormone gene construct.

Authors:  S J Du; Z Y Gong; G L Fletcher; M A Shears; M J King; D R Idler; C L Hew
Journal:  Biotechnology (N Y)       Date:  1992-02

2.  Assessing unintended effects of a mammary-specific transgene at the whole animal level in host and non-target animals.

Authors:  Merritt Clark; James D Murray; Elizabeth A Maga
Journal:  Transgenic Res       Date:  2013-11-09       Impact factor: 2.788

3.  The effect of mammary gland expression of human lysozyme on the properties of milk from transgenic mice.

Authors:  E A Maga; G B Anderson; J D Murray
Journal:  J Dairy Sci       Date:  1995-12       Impact factor: 4.034

4.  Isolation, partial sequence and asynchronous appearance during lactation of lysozyme and alpha-lactalbumin in the milk of a marsupial, the common ringtail possum (Pseudocheirus peregrinus).

Authors:  K Nicholas; M Loughnan; M Messer; S Munks; M Griffiths; D Shaw
Journal:  Comp Biochem Physiol B       Date:  1989

5.  Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes.

Authors:  R D Palmiter; R L Brinster; R E Hammer; M E Trumbauer; M G Rosenfeld; N C Birnberg; R M Evans
Journal:  Nature       Date:  1982-12-16       Impact factor: 49.962

6.  Synergistic effects of ovine-derived cathelicidins and other antimicrobials against Escherichia coli O157:H7 and Staphylococcus aureus 1056 MRSA.

Authors:  Danitsja S van der Linden; David Short; Antje Dittmann; Pak-Lam Yu
Journal:  Biotechnol Lett       Date:  2009-04-26       Impact factor: 2.461

7.  Lactoferrin as a natural regimen for selective decontamination of the digestive tract: recombinant porcine lactoferrin expressed in the milk of transgenic mice protects neonates from pathogenic challenge in the gastrointestinal tract.

Authors:  Chih-Ching Yen; Chien-Yu Lin; Kowit-Yu Chong; Tung-Chou Tsai; Chih-Jie Shen; Ming-Fong Lin; Chun-Yao Su; Hsiao-Ling Chen; Chuan-Mu Chen
Journal:  J Infect Dis       Date:  2009-02-15       Impact factor: 5.226

8.  Generation of transgenic dairy cattle using 'in vitro' embryo production.

Authors:  P Krimpenfort; A Rademakers; W Eyestone; A van der Schans; S van den Broek; P Kooiman; E Kootwijk; G Platenburg; F Pieper; R Strijker
Journal:  Biotechnology (N Y)       Date:  1991-09

9.  Binding of lysozyme to lipopolysaccharide suppresses tumor necrosis factor production in vivo.

Authors:  K Takada; N Ohno; T Yadomae
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

10.  Consuming transgenic goats' milk containing the antimicrobial protein lysozyme helps resolve diarrhea in young pigs.

Authors:  Caitlin A Cooper; Lydia C Garas Klobas; Elizabeth A Maga; James D Murray
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

View more
  17 in total

1.  Opinion: A new paradigm for regulating genetically engineered animals that are used as food.

Authors:  J D Murray; E A Maga
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-29       Impact factor: 11.205

Review 2.  Strategies to enable the adoption of animal biotechnology to sustainably improve global food safety and security.

Authors:  Mark Tizard; Eric Hallerman; Scott Fahrenkrug; Martina Newell-McGloughlin; John Gibson; Frans de Loos; Stefan Wagner; Götz Laible; Jae Yong Han; Michael D'Occhio; Lisa Kelly; John Lowenthal; Kari Gobius; Primal Silva; Caitlin Cooper; Tim Doran
Journal:  Transgenic Res       Date:  2016-05-31       Impact factor: 2.788

3.  Development of dairy herd of transgenic goats as biofactory for large-scale production of biologically active recombinant human lactoferrin.

Authors:  I Semak; A Budzevich; E Maliushkova; V Kuzniatsova; N Popkov; I Zalutsky; O Ivashkevich
Journal:  Transgenic Res       Date:  2019-08-08       Impact factor: 2.788

4.  Functional evaluation of a monotreme-specific antimicrobial protein, EchAMP, against experimentally induced mastitis in transgenic mice.

Authors:  Manjusha Neerukonda; Sivapriya Pavuluri; Isha Sharma; Alok Kumar; Purnima Sailasree; Jyothi B Lakshmi; Julie A Sharp; Satish Kumar
Journal:  Transgenic Res       Date:  2019-10-10       Impact factor: 2.788

5.  Effect of Continuous Administration of Enalapril Maleate on the Oocyte Quality and In Vitro Production of Parthenote Embryos in Nulliparous and Multiparous Goats Undergoing Serial Laparoscopic Ovum Pick-Up.

Authors:  Pamela A Bravo; Maria E Moreno; César C L Fernandes; Rafael Rossetto; Camila M Cavalcanti; Denilsa P Fernandes; Davide Rondina
Journal:  Animals (Basel)       Date:  2019-10-26       Impact factor: 2.752

6.  One-step Multiplex Transgenesis via Sleeping Beauty Transposition in Cattle.

Authors:  Wiebke Garrels; Thirumala R Talluri; Ronja Apfelbaum; Yanet P Carratalá; Pablo Bosch; Kerstin Pötzsch; Esther Grueso; Zoltán Ivics; Wilfried A Kues
Journal:  Sci Rep       Date:  2016-02-24       Impact factor: 4.379

7.  Increased gene dosage for β- and κ-casein in transgenic cattle improves milk composition through complex effects.

Authors:  Götz Laible; Grant Smolenski; Thomas Wheeler; Brigid Brophy
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

Review 8.  pH Dependent Antimicrobial Peptides and Proteins, Their Mechanisms of Action and Potential as Therapeutic Agents.

Authors:  Erum Malik; Sarah R Dennison; Frederick Harris; David A Phoenix
Journal:  Pharmaceuticals (Basel)       Date:  2016-11-01

Review 9.  Lactoferrin from Milk: Nutraceutical and Pharmacological Properties.

Authors:  Francesco Giansanti; Gloria Panella; Loris Leboffe; Giovanni Antonini
Journal:  Pharmaceuticals (Basel)       Date:  2016-09-27

10.  A PiggyBac mediated approach for lactoferricin gene transfer in bovine mammary epithelial stem cells for management of bovine mastitis.

Authors:  Neelesh Sharma; Do Luong Huynh; Sung Woo Kim; Mrinmoy Ghosh; Simrinder Singh Sodhi; Amit Kumar Singh; Nam Eun Kim; Sung Jin Lee; Kafil Hussain; Sung Jong Oh; Dong Kee Jeong
Journal:  Oncotarget       Date:  2017-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.